Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment.
about
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastasesSustained complete remission of human epidermal growth factor receptor 2-positive metastatic breast cancer in the liver during long-term trastuzumab (Herceptin) maintenance therapy in a woman: a case report.Capecitabine maintenance therapy for XT chemotherapy-sensitive patients with metastatic triple-negative breast cancerFirst-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients.Extending the duration of first-line chemotherapy in metastatic breast cancer: a perspective review.Maintenance hormonal treatment improves progression free survival after a first line chemotherapy in patients with metastatic breast cancerCapecitabine maintenance therapy in patients with recurrent or metastatic breast cancer.Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review.Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02).Additional dexamethasone in chemotherapies with carboplatin and paclitaxel could reduce the impaired glycometabolism in rat models.Outcome of patients with metastatic breast carcinoma treated at a private medical oncology clinic.
P2860
Q28344321-A82464BF-C19B-4191-A28C-2E85FD7C738EQ33264119-CAF9A717-5231-49E0-A399-E6610B8EE1BEQ34419517-23255E33-680A-4531-983E-9F4829E70474Q34452707-EAF49C7B-3DC6-4DA0-BDBF-D1751D3BA258Q34993796-E6B67A4F-3435-43A6-BD44-A3E54075365FQ35205290-B9746138-5990-4B78-B82D-0E8B41E9F3D2Q36632687-AB936F4F-7404-4106-977E-7FF12420BCE3Q37604159-3F4A2752-19C1-4FD3-9AA6-4CA2D6823559Q38782118-E2D4FDAB-F66C-4B77-BF9A-368333A127F3Q41701535-98B77842-D0E3-4B34-9B0E-238CBF843FA1Q47552772-13C4AA49-9DEE-4108-9A7A-D9F66A22FC33Q47691132-8B39E04A-E636-4433-8D61-A4E12D602306
P2860
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Eastern Cooperative Oncology G ...... following induction treatment.
@ast
Eastern Cooperative Oncology G ...... following induction treatment.
@en
type
label
Eastern Cooperative Oncology G ...... following induction treatment.
@ast
Eastern Cooperative Oncology G ...... following induction treatment.
@en
prefLabel
Eastern Cooperative Oncology G ...... following induction treatment.
@ast
Eastern Cooperative Oncology G ...... following induction treatment.
@en
P2093
P1476
Eastern Cooperative Oncology G ...... following induction treatment.
@en
P2093
C K Osborne
F J Cummings
G W Sledge
K J Pandya
M D Abeloff
R S Gelman
P304
P356
10.1200/JCO.1998.16.5.1669
P407
P577
1998-05-01T00:00:00Z